Literature DB >> 7020503

The relationship between arterial blood gases and serum theophylline clearance in critically ill patients.

B T Westerfield, A J Carder, R W Light.   

Abstract

Theophylline clearances were monitored at 8-h intervals in a group of critically ill patients and changes in the clearances were correlated with changes in the arterial blood gases. A total of 183 samples from 20 patients were analyzed. The initial theophylline clearance ranged from 20 to 89 ml/kg/h. The initial clearances could not be predicted from the patient's age, arterial blood gases, or the presence of congestive heart failure, liver dysfunction, or other medical problems. For individual patients, the theophylline clearance varied markedly during the study, with the mean maximal clearance averaging 54% higher than the mean minimal clearance. Changes in clearances were not correlated with changes in the arterial blood gases. On the basis of this study, we recommend an initial aminophylline infusion rate of 0.5 mg/kg/h in all critically ill patients. Serum theophylline concentrations should then be determined at 24-h intervals until stabilization and at 48-h intervals thereafter with appropriate adjustments in aminophylline doses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020503     DOI: 10.1164/arrd.1981.124.1.17

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  What role for theophylline?

Authors:  J W Jenne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 2.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 3.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 4.  Hypoxia, arterial pH and theophylline disposition.

Authors:  M Richer; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 5.  Acute respiratory failure and chronic obstructive lung disease.

Authors:  R L Rosen
Journal:  Med Clin North Am       Date:  1986-07       Impact factor: 5.456

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.